Tiziana Life Sciences, PLC   Report issue

For profit Phase 2
Founded: Mayfair United Kingdom (2013)

Organization Overview

First Clinical Trial
2013
NCT01011439
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Tiziana Life Sciences LTD | Tiziana Life Sciences, PLC

Active Ingredients

Drugs in Phase 2 Trials (3)

foralumab (4 trials)

milciclib (4 trials)

omeprazole (prilosec) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma (Phase 2)

Carcinoma, Hepatocellular (Phase 2)

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Fatty Liver (Phase 2)

Non-alcoholic Fatty Liver Disease (Phase 2)

Thymoma (Phase 2)

Thymus Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 8
  • # of Trial APIs: 3